Industry Theaters
Industry Theaters are presentations developed by sponsoring companies that highlight medical devices, medical technology, non-FDA-approved pharmaceutical products, investigational products or devices in pipeline or clinical trial phases, and patient treatment resources. Sessions are non-CME and solely promotional in nature.
Advancing Care in Primary Central Nervous System Lymphoma: Evolving Treatment Approaches
Sponsored by Deciphera – A Member of ONO PharmaMonday, December 14, 2026
8:00 a.m. - 9:00 a.m.
MCCNO - 288-290
This presentation is intended for U.S. based registered meeting attendees
For in-person participants only
Beyond BCMA: Investigating GPRC5D CAR T Therapy in RRMM
Sponsored by Bristol Myers SquibbMonday, December 14, 2026
8:00 a.m. - 9:00 a.m.
MCCNO - Hall J Theater 5
For in-person participants only
Beyond Bone Marrow: Integrating Circulating Plasma Cell Enumeration and Genomic Profiling into Multiple Myeloma Disease Assessment
Sponsored by Menarini Silicon BiosystemsSunday, December 13, 2026
8:00 a.m. - 9:00 a.m.
MCCNO - Hall J Theater 5
This presentation is intended for U.S. based registered meeting attendees
For in-person participants only
Building the Evidence: Novo Nordisk's Investigational Clinical Development in Sickle Cell Disease and Thalassemia
Sponsored by Novo Nordisk Healthcare AGMonday, December 14, 2026
12:15 p.m. - 1:15 p.m.
MCCNO - Hall J Theater 6
For in-person participants only
Hemolysis in Sickle Cell Disease (SCD): Connecting Biology, Clinical Outcomes, and the Lived Experience
Sponsored by Agios PharmaceuticalsMonday, December 14, 2026
8:00 a.m. - 9:00 a.m.
MCCNO - Hall J Theater 6
For in-person participants only
This session will include a perspective from a patient living with sickle cell disease
Integrated Innovation in Cell Therapy: From Manufacturing to Clinical Development
Sponsored by Miltenyi BiomedicineMonday, December 14, 2026
8:00 a.m. - 9:00 a.m.
MCCNO - Hall J Theater 4
For in-person participants only
When Pediatric Care Ends, What Comes Next for Patients With PROS and Lymphatic Malformations?
Sponsored by Novartis Pharmaceuticals CorporationSunday, December 13, 2026
8:00 a.m. - 9:00 a.m.
MCCNO - Hall J Theater 1
For in-person participants only
This session will include a perspective from a patient advocate